shire plc (SHP:London Stock Exchange)
David Ginsburg M.D.
Independent Non-Executive Director and Chairman of Science & Technology Committee, Shire plc
|Age||Total Calculated Compensation||This person is connected to 33 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Dr. David Ginsburg, M.D., serves as Investigator of the Howard Hughes Medical Institute. Dr. Ginsburg is a James V. Neel Distinguished University Profession of Internal Medicine and Human Genetics, a Warner-Lambert/Parke-Davis Professor of Medicine. He serves as member of the Life Sciences Institute at the University of Michigan Medical School. He has been Independent Non Executive Director of Shire plc since June 16, 2010. He has been a Member of Scientific Advisory ...
5 RiverwalkPhone: 353 1 429 7700
Dublin, Co. Dublin 24
Board Members Memberships*
Independent Non-Executive Director and Chairman of Science & Technology Committee
Harvard Medical School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|David E. I. Pyott||Chairman and Chief Executive Officer|
|Heather Bresch||Chief Executive Officer, Director and Member of Science & Technology Committee|
|J. Michael Pearson||Chairman and Chief Executive Officer|
Valeant Pharmaceuticals International, Inc.
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|Paul R. Perreault BA Psychology||Chief Executive Officer, Managing Director, Executive Director and Member of Innovation & Development Committee|
|$3.1M||Compensation as of Fiscal Year 2013.|